Enhancement of dissolution rate of racecadotril by liquisolid compact technology

Abstract The current investigation was used to improve the rate of dissolution of an anti-diarrheal drug i.e., racecadotril (RT) at low pH conditions (i.e., in the stomach) by reducing the water secretion and electrolyte in to the intestine by liquisolid tablets. Different formulations (liquisolid)...

Full description

Bibliographic Details
Main Authors: Bhaskar Daravath, Shalini Somalanka
Format: Article
Language:English
Published: Universidade de São Paulo 2023-01-01
Series:Brazilian Journal of Pharmaceutical Sciences
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502022000100846&tlng=en
_version_ 1828068166089048064
author Bhaskar Daravath
Shalini Somalanka
author_facet Bhaskar Daravath
Shalini Somalanka
author_sort Bhaskar Daravath
collection DOAJ
description Abstract The current investigation was used to improve the rate of dissolution of an anti-diarrheal drug i.e., racecadotril (RT) at low pH conditions (i.e., in the stomach) by reducing the water secretion and electrolyte in to the intestine by liquisolid tablets. Different formulations (liquisolid) were prepared using Avicel PH 102 as a carrier. Aerosil 200 as a coating material and sodium starch glycolate used as a disintegrant. Polyethylene glycol 200 was used as a non-volatile vehicle to dissolve the drug. FTIR, DSC, XRD and dissolution studies were conducted to characterise liquisolid tablets. Characterisation studies indicated that no interactions between carrier and drug. Solid state characterization had shown a reduction in crystallinity that further supports increment in solubility and dissolution. The optimised formulation showed a significant increase in dissolution i.e., 99.54±0.62% in 30 min compared to directly compressible tablets (38.47±0.26%). The % dissolution efficiency of racecadotril liquisolid tablets 76.86% compared to marketed tablet (27.56%) and conventional direct compression tablet (17.11%). Significant reduction in mean dissolution time of racecadotril from liquisolid tablets (6.84 min) compared to direct compression tablet (44.57 min), indicating faster release of drug and faster onset of action. Formulation of liquisolid tablets could enhance solubility, dissolution and bioavailability of racecadotril.
first_indexed 2024-04-10T23:58:40Z
format Article
id doaj.art-2bc75ed6b9fb41cea9b78dae102dc0cd
institution Directory Open Access Journal
issn 2175-9790
language English
last_indexed 2024-04-10T23:58:40Z
publishDate 2023-01-01
publisher Universidade de São Paulo
record_format Article
series Brazilian Journal of Pharmaceutical Sciences
spelling doaj.art-2bc75ed6b9fb41cea9b78dae102dc0cd2023-01-10T07:34:59ZengUniversidade de São PauloBrazilian Journal of Pharmaceutical Sciences2175-97902023-01-015810.1590/s2175-97902022e21044Enhancement of dissolution rate of racecadotril by liquisolid compact technologyBhaskar Daravathhttps://orcid.org/0000-0001-8181-4134Shalini SomalankaAbstract The current investigation was used to improve the rate of dissolution of an anti-diarrheal drug i.e., racecadotril (RT) at low pH conditions (i.e., in the stomach) by reducing the water secretion and electrolyte in to the intestine by liquisolid tablets. Different formulations (liquisolid) were prepared using Avicel PH 102 as a carrier. Aerosil 200 as a coating material and sodium starch glycolate used as a disintegrant. Polyethylene glycol 200 was used as a non-volatile vehicle to dissolve the drug. FTIR, DSC, XRD and dissolution studies were conducted to characterise liquisolid tablets. Characterisation studies indicated that no interactions between carrier and drug. Solid state characterization had shown a reduction in crystallinity that further supports increment in solubility and dissolution. The optimised formulation showed a significant increase in dissolution i.e., 99.54±0.62% in 30 min compared to directly compressible tablets (38.47±0.26%). The % dissolution efficiency of racecadotril liquisolid tablets 76.86% compared to marketed tablet (27.56%) and conventional direct compression tablet (17.11%). Significant reduction in mean dissolution time of racecadotril from liquisolid tablets (6.84 min) compared to direct compression tablet (44.57 min), indicating faster release of drug and faster onset of action. Formulation of liquisolid tablets could enhance solubility, dissolution and bioavailability of racecadotril.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502022000100846&tlng=enAvicelAerosilNon-volatile vehicleLiquisolid tabletsDissolution
spellingShingle Bhaskar Daravath
Shalini Somalanka
Enhancement of dissolution rate of racecadotril by liquisolid compact technology
Brazilian Journal of Pharmaceutical Sciences
Avicel
Aerosil
Non-volatile vehicle
Liquisolid tablets
Dissolution
title Enhancement of dissolution rate of racecadotril by liquisolid compact technology
title_full Enhancement of dissolution rate of racecadotril by liquisolid compact technology
title_fullStr Enhancement of dissolution rate of racecadotril by liquisolid compact technology
title_full_unstemmed Enhancement of dissolution rate of racecadotril by liquisolid compact technology
title_short Enhancement of dissolution rate of racecadotril by liquisolid compact technology
title_sort enhancement of dissolution rate of racecadotril by liquisolid compact technology
topic Avicel
Aerosil
Non-volatile vehicle
Liquisolid tablets
Dissolution
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502022000100846&tlng=en
work_keys_str_mv AT bhaskardaravath enhancementofdissolutionrateofracecadotrilbyliquisolidcompacttechnology
AT shalinisomalanka enhancementofdissolutionrateofracecadotrilbyliquisolidcompacttechnology